Myriad Genetics Inc (MYGN)
13.65
+0.29
(+2.17%)
USD |
NASDAQ |
Dec 23, 16:00
13.65
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Debt to Equity Ratio: 0.0533 for Sept. 30, 2024
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Haemonetics Corp | 1.394 |
| Boston Scientific Corp | 0.5254 |
| Globus Medical Inc | 0.1074 |
| ResMed Inc | 0.1304 |
| Perspective Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.081B |
| Total Liabilities (Quarterly) | 349.60M |
| Shareholders Equity (Quarterly) | 731.70M |
| Current Ratio | 1.900 |
| Net Debt Paydown Yield | -0.00% |